October 2006 Update of the Hospital OPPS: Summary of Payment Policy Changes

• "Drugs and Biologics with Payment Rates Based on Average Sales Price (ASP) Effective October 1, 2006 (page 4 of document)"
• "Newly Approved Drug Eligible for Pass-Through Status (Decitabine per 1mg)"
• "Updated Payment Rate for HCPCS C9227--Injection-Micafungin Sodium per 1 mg"
• "Updated Payment Rate for Abatacept HCPCS C9230"
• "Zoster Vaccine approved for payment under OPPS"
• "Correct reporting of units for drugs"